Marc Cluzel, M.D., Ph.D.


  • Year of birth 1955
  • Nationality French
  • Place of residence Montpellier, France
  • Initial appointment 2012
  • End of current period 2024

Professional Development

Currently Member of the Supervisory Board of MorphoSys AG as well as member of comparable foreign supervisory board of a commercial enterprise (see below)

2011 - 2012 Executive Vice President of Product Development, HÙYÀ Bioscience International, LLC, San Diego, CA, USA

2009 - 2010 Executive Vice President of Research & Development, Sanofi-Aventis S.A., Paris, France

2007 - 2009 Senior Vice President of Science and Medical Affairs, Sanofi-Aventis S.A., Paris, France

2002 - 2011 Chairman and CEO, Sanofi-Aventis R&D France, Paris, France

1996 - 2001 Head of Project Direction, Sanofi R&D France, Paris, France

1993 - 1996 Project Director, Sanofi R&D France, Paris, France

1991 - 1993 Clinical Pharmacologist, Sanofi R&D France, Montpellier, France


1983 - 1990 Ph.D. Biochemistry at University of Montpellier, France

1973 - 1985 M.D., Study of Medicine at University of Montpellier, France

Memberships in Statutory Supervisory Boards and/or in Comparable Domestic or Foreign Supervisory Bodies of Commercial Enterprises Section

Moleac Pte. Ltd., Singapore* Member of the Board of Directors

Griffon Pharmaceuticals Inc., Montreal, Kanada* Member of the Board of Directors

*not publicly listed company
As of March 2022